PINK is an exchange-traded fund that seeks long-term capital appreciation by providing investors with multi-cap exposure to innovative companies in biotechnology, medical technology, gene therapy, and other revolutionary healthcare-related sectors. It combines the active stock selection, rigorous company and industry research, and due diligence processes of a hedge fund, with the daily liquidity, low cost, and tax efficiencies of an ETF.
*as of November 8, 2021